Home Business Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs

Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs

by news

There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, but Novo Nordisk’s new data is a meaningful start.
source

Related Posts